November 10, 2025

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 12.64% Potential Upside Amidst Healthcare Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors driven by a noteworthy 12.64% potential..

Johnson & Johnson (JNJ) Stock Analysis: Exploring the 6.96% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to draw investor attention with its robust market presence and promising growth indicators. The company’s market capitalization stands..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 10% Potential Upside in the Healthcare Giant

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, stands out with a market capitalization of $387.34 billion. As a prominent biopharmaceutical company, AbbVie engages in the research,..

Zoetis Inc. (ZTS) Stock Analysis: Unpacking a 45% Potential Upside for Investors

Investors with an eye on the healthcare sector might find Zoetis Inc. (NYSE: ZTS) a compelling opportunity, especially given its potential upside of 45.51% as highlighted by the average analyst..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and Dividend Potential

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, stands as a formidable entity in the global pharmaceutical landscape. With a market capitalization of $242.74 billion, the Swiss-based..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Healthcare Giant with a 15.46% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a leading player in the global healthcare sector, presents an intriguing opportunity for investors seeking exposure in the drug manufacturing industry. With a market capitalization..

Molina Healthcare Inc (MOH) Investor Outlook: Navigating Upside Potential Amidst Healthcare Sector Dynamics

Molina Healthcare Inc (NYSE: MOH), a formidable player in the healthcare plans industry, presents a fascinating prospect for investors seeking opportunities within the healthcare sector. With a market capitalization of..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing a 56% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices industry, is capturing the attention of investors with a notable 56.29% potential upside, as indicated by current analyst ratings. With..

Novo Nordisk A/S (NVO) Investor Outlook: Assessing a 30.71% Upside Potential

Novo Nordisk A/S (NYSE: NVO) stands as a towering entity in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $210.03 billion, this Danish pharmaceutical..

STERIS plc (STE) Stock Analysis: Exploring 5.82% Upside Potential and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents an intriguing prospect. With a market capitalization of $25.89 billion, this leading player in infection prevention products..

Edwards Lifesciences Corporatio (EW)

⚠️ No article content returned.

..

Gilead Sciences, Inc. (GILD) Stock Analysis: A Solid 8.98% Upside Potential Beckons Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, continues to captivate investor interest with its robust portfolio in the drug manufacturing industry. With a market capitalization of..

The Cigna Group (CI) Stock Analysis: Investor Outlook with a 24.96% Potential Upside

The Cigna Group (CI), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth outlook. With a market capitalization of $70.68..

Humana Inc. (HUM) Stock Analysis: Exploring a 14.45% Potential Upside in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the healthcare plans industry, has captured investor attention with its robust operational framework and an intriguing potential upside of 14.45%. With a..

AstraZeneca PLC (AZN) Stock Analysis: Unveiling a 10.35% Upside Potential in the Healthcare Giant

AstraZeneca PLC (AZN) stands as a prominent player in the healthcare sector, particularly within the general drug manufacturing industry. This biopharmaceutical powerhouse, headquartered in Cambridge, UK, is making significant strides..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a 2.15% Potential Upside in the Diagnostics & Research Industry

Agilent Technologies, Inc. (NYSE: A), a notable player in the Healthcare sector, specifically in the Diagnostics & Research industry, is currently trading at $146.74 with a slight decrease of 0.75..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Leading Player in Healthcare with Limited Upside

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates an extensive network of hospitals and healthcare facilities across the United States. With a market capitalization of $108.76..

UnitedHealth Group (UNH) Stock Analysis: Exploring an 18.87% Potential Upside for Savvy Investors

As a titan in the healthcare sector, UnitedHealth Group Incorporated (NYSE: UNH) stands at the intersection of medical services and financial acumen. With a sprawling empire that encompasses healthcare plans,..

Alcon Inc. (ALC) Stock Analysis: Insights into a 28.60% Potential Upside in Eye Care Innovation

For investors with an eye on the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling opportunity. Specializing in eye care products, Alcon is a Swiss-based company with a substantial..

Bristol-Myers Squibb (BMY) Stock Analysis: Investor Insights on 13.92% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) stands as a pillar in the healthcare sector, particularly in the realm of general drug manufacturing. With a robust market capitalization of $95.05 billion, this..

Search

Funds

November 10, 2025

Search

Funds

November 10, 2025

FTSE 100

Funds